Back to top

Image: Bigstock

Eleven Biotherapeutics (EBIO) Jumps: Stock Rises by 10.4%

Read MoreHide Full Article

Eleven Biotherapeutics, Inc. was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 134% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.Eleven Biotherapeutics currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the same industry is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy).

Is EBIO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


ANI Pharmaceuticals, Inc. (ANIP) - free report >>

Published in